This article provides a comprehensive guide for researchers and scientists on validating Flux Balance Analysis (FBA) predictions against experimental 13C metabolic flux analysis (13C-MFA) data.
This article provides a comprehensive comparison of two cornerstone methods in metabolic analysis: 13C-Metabolic Flux Analysis (13C-MFA) and Flux Balance Analysis (FBA).
Flux Balance Analysis (FBA) has long been a cornerstone for predicting metabolic phenotypes, yet its quantitative accuracy is limited by assumptions like static objective functions and the omission of proteomic...
Flux Balance Analysis (FBA) is a cornerstone of constraint-based metabolic modeling, but its predictions are often non-unique, with numerous alternative optimal solutions yielding the same objective value.
This article provides a comprehensive overview of gap-filling strategies in genome-scale metabolic model (GEM) reconstruction, a critical process for converting genomic information into predictive computational frameworks.
This article provides a comprehensive guide for researchers and drug development professionals on correcting for errors in Mass Isotopomer Distribution (MID) measurements, a critical component of stable isotope labeling experiments...
This article provides a comprehensive guide for researchers and drug development professionals on improving the precision of glycolytic and pentose phosphate pathway (PPP) flux measurements.
Accurate quantification of flux uncertainty is critical for validating therapeutic targets, optimizing microbial cell factories, and ensuring the reliability of metabolic models in biomedical research.
Flux bound uncertainty remains a significant challenge in genome-scale metabolic models (GEMs), limiting their predictive accuracy and application in biomedical research and drug development.
Thermodynamically infeasible cycles (TICs) in metabolic models create significant challenges, limiting the predictive accuracy of flux distributions essential for understanding cellular behavior and optimizing bioprocesses like pharmaceutical production.